2.8599 USD
-0.05 (-1.72%)
We assign a fundamental rating of 3 out of 10 to UPXI. UPXI was compared to 36 industry peers in the Personal Care Products industry. Both the profitability and financial health of UPXI have multiple concerns. UPXI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year UPXI has reported negative net income.
In the past year UPXI has reported a negative cash flow from operations.
UPXI had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: UPXI reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -11.05%, UPXI is doing worse than 72.22% of the companies in the same industry.
With a Return On Equity value of -15.19%, UPXI perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.05% | ||
| ROE | -15.19% | ||
| ROIC | N/A |
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
UPXI's Gross Margin of 68.74% is in line compared to the rest of the industry. UPXI outperforms 55.56% of its industry peers.
In the last couple of years the Gross Margin of UPXI has grown nicely.
The Profit Margin and Operating Margin are not available for UPXI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.74% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
2. Health
2.1 Basic Checks
UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
UPXI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, UPXI has more shares outstanding
Compared to 1 year ago, UPXI has an improved debt to assets ratio.
2.2 Solvency
UPXI has an Altman-Z score of 2.44. This is not the best score and indicates that UPXI is in the grey zone with still only limited risk for bankruptcy at the moment.
UPXI has a Altman-Z score of 2.44. This is comparable to the rest of the industry: UPXI outperforms 52.78% of its industry peers.
UPXI has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
UPXI has a Debt to Equity ratio (0.22) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.44 |
ROIC/WACCN/A
WACC8.23%
2.3 Liquidity
A Current Ratio of 1.74 indicates that UPXI should not have too much problems paying its short term obligations.
UPXI has a Current ratio of 1.74. This is comparable to the rest of the industry: UPXI outperforms 41.67% of its industry peers.
UPXI has a Quick Ratio of 1.71. This is a normal value and indicates that UPXI is financially healthy and should not expect problems in meeting its short term obligations.
UPXI has a better Quick ratio (1.71) than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
UPXI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.38%, which is quite impressive.
The Revenue for UPXI has decreased by -70.36% in the past year. This is quite bad
UPXI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.37% yearly.
EPS 1Y (TTM)69.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.37%
Revenue 1Y (TTM)-70.36%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%112.77%
3.2 Future
The Earnings Per Share is expected to grow by 27.26% on average over the next years. This is a very strong growth
UPXI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 67.30% yearly.
EPS Next Y103.26%
EPS Next 2Y27.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year147.95%
Revenue Next 2Y67.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for UPXI. In the last year negative earnings were reported.
UPXI is valuated quite expensively with a Price/Forward Earnings ratio of 93.46.
UPXI's Price/Forward Earnings ratio is in line with the industry average.
UPXI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 93.46 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UPXI's earnings are expected to grow with 27.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.26%
EPS Next 3YN/A
5. Dividend
5.1 Amount
UPXI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:UPXI (12/4/2025, 2:01:46 PM)
2.8599
-0.05 (-1.72%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners46.96%
Inst Owner Change122.18%
Ins Owners6.91%
Ins Owner Change2.69%
Market Cap171.37M
Revenue(TTM)15.81M
Net Income(TTM)-13.68M
Analysts82.5
Price Target15.81 (452.82%)
Short Float %18.77%
Short Ratio1.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-36.72%
Min Revenue beat(2)-82.88%
Max Revenue beat(2)9.44%
Revenue beat(4)1
Avg Revenue beat(4)-56.02%
Min Revenue beat(4)-82.88%
Max Revenue beat(4)9.44%
Revenue beat(8)1
Avg Revenue beat(8)-75.73%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)133.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)53.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 93.46 | ||
| P/S | 10.84 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.9 | ||
| P/tB | 5.19 | ||
| EV/EBITDA | N/A |
EPS(TTM)-5.91
EYN/A
EPS(NY)0.03
Fwd EY1.07%
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.26
BVpS1.5
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.05% | ||
| ROE | -15.19% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.74% | ||
| FCFM | N/A |
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
F-Score5
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 13895.3% | ||
| Cap/Sales | 665.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z | 2.44 |
F-Score5
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)4646.3%
Cap/Depr(5y)2855.28%
Cap/Sales(3y)223.57%
Cap/Sales(5y)140.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.37%
EPS Next Y103.26%
EPS Next 2Y27.26%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-70.36%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%112.77%
Revenue Next Year147.95%
Revenue Next 2Y67.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10898.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8206.71%
OCF growth 3YN/A
OCF growth 5YN/A
UPEXI INC / UPXI FAQ
Can you provide the ChartMill fundamental rating for UPEXI INC?
ChartMill assigns a fundamental rating of 3 / 10 to UPXI.
What is the valuation status for UPXI stock?
ChartMill assigns a valuation rating of 2 / 10 to UPEXI INC (UPXI). This can be considered as Overvalued.
Can you provide the profitability details for UPEXI INC?
UPEXI INC (UPXI) has a profitability rating of 1 / 10.
How financially healthy is UPEXI INC?
The financial health rating of UPEXI INC (UPXI) is 3 / 10.